Press Release Sagimet Biosciences Receives FDA “Study May Proceed” Letter and IND Clearance for Phase 3 Trial in Acne in Adolescent and Adult Patients Sagimet Biosciences Inc. · Aug 13
Press Release Fieldguide Research Finds AI-Native Audit and Advisory Firms Significantly Outperform Casual AI Adopters on Profitability, Capacity, and Retention Fieldguide Inc. · Aug 13
Press Release American Shared Hospital Services Reports Second Quarter and First Half 2026 Financial Results American Shared Hospital Services · Aug 13
Press Release LENSAR® Reports Second Quarter 2026 Results and Provides Business Update LENSAR, Inc. · Aug 13
Press Release Calian Reports Record Results for the Third Quarter of Fiscal 2026 Calian Group Ltd. · Aug 13
Press Release Parabilis Medicines Reports Second Quarter 2026 Financial Results and Provides Business Updates Parabilis Medicines, Inc. · Aug 13
Press Release Biomea Fusion Announces First Patient Dosed in OPAL Study Evaluating Icovamenib in Combination with Semaglutide in Obesity Biomea Fusion, Inc. · Aug 13
Press Release Cellebrite Appoints Shiven Ramji Chief Executive Officer, Succeeding Thomas E. Hogan Cellebrite · Aug 13
Press Release Ardagh Holdings S.A. Files Amendment to Schedule 13D with the U.S. Securities and Exchange Commission Regarding Ardagh Metal Packaging S.A. Ardagh Group S.A. · Aug 13
Press Release E-STORAGE’s KuBank 3.0 for C&I Applications Successfully Passes Large-Scale Fire Testing Canadian Solar Inc. · Aug 13
Press Release Accro Bioscience to Present Phase Ib Data of AC-101, an Oral Selective RIPK2 Inhibitor, for Moderate-to-Severe UC at UEG Week 2026 in Barcelona Accro Bioscience Inc. · Aug 13
Press Release NACCE Short Tracks Career Paths at NASCAR National Association for Community College Entrepreneurship · Aug 13